Randomized controlled study comparing the Gynecare Morcellex and Rotocut G1 tissue morcellators.
OBJECTIVE
To evaluate the effectiveness of the Gynecare Morcellex tissue morcellator (Ethicon, Inc., Somerville, NJ) in laparoscopic supracervical hysterectomy and myomectomy.


METHODS
Randomized controlled trial (Evidence I).


METHODS
University department of obstetrics and gynecology.


METHODS
Seventy-four patients with symptomatic uterine myomas scheduled for laparoscopic supracervical hysterectomy or myomectomy.


METHODS
Laparoscopic supracervical hysterectomy and myomectomy followed by tissue morcellation using the Gynecare Morcellex (experimental group) or the Rotocut G1 morcellator (Karl Storz GmbH & Co. KG, Tuttlingen, Germany) (control group).


RESULTS
Patient characteristics and surgical data were noted for both groups. No difference was detected between groups in any parameters assessed, whereas a significant difference (p <.05) in handling score was detected in the experimental group compared with the control group.


CONCLUSIONS
The Gynecare Morcellex is an effective instrument with excellent safety and handling.
Department of Obstetrics, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Fulvio
F
Zullo
Angela
A
Falbo
Assunta
A
Iuliano
Rosamaria
R
Oppedisano
Angela
A
Sacchinelli
Gianluca
G
Annunziata
Roberta
R
Venturella
Caterina
C
Materazzo
Achille
A
Tolino
Stefano
S
Palomba
D000328:Adult; D003362:Cost-Benefit Analysis; D004598:Electrosurgery / Q000191:economics / Q000295:instrumentation*; D004867:Equipment Design; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000191:economics / Q000295:instrumentation*; D010535:Laparoscopy; D007889:Leiomyoma / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D016896:Treatment Outcome; D047368:Tumor Burden; D014594:Uterine Neoplasms / Q000473:pathology / Q000601:surgery*